Viewing Study NCT02512692


Ignite Creation Date: 2025-12-24 @ 3:57 PM
Ignite Modification Date: 2026-02-23 @ 1:11 AM
Study NCT ID: NCT02512692
Status: TERMINATED
Last Update Posted: 2024-11-18
First Post: 2015-07-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemcitabine-Cisplatin-90Y TARE for Unresectable Intrahepatic Cholangiocarcinoma
Sponsor: Medical University of South Carolina
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-07-21
Start Date Type: ACTUAL
Primary Completion Date: 2021-03-19
Primary Completion Date Type: ACTUAL
Completion Date: 2021-03-19
Completion Date Type: ACTUAL
First Submit Date: 2015-07-29
First Submit QC Date: None
Study First Post Date: 2015-07-31
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-11-15
Last Update Post Date: 2024-11-18
Last Update Post Date Type: ACTUAL